Variant report

Variant	nsv510767
Chromosome Location	chr19:41962486-42049165
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1335)
CpG islands
(count:305)
Chromatin interactive
region (count:18)
LncRNA
region (count:42)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1335 , 50 per page) page: 1 2 3 4 5 6 7 ... 27

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:42044288-42044433	K562	blood:	n/a	n/a
2	ARID3A	chr19:42048361-42048501	HepG2	liver:	n/a	n/a
3	ARID3A	chr19:41969568-41969577	HepG2	liver:	n/a	n/a
4	ARID3A	chr19:41985894-41986022	K562	blood:	n/a	n/a
5	ATF1	chr19:41985515-41985820	K562	blood:	n/a	n/a
6	ATF1	chr19:42034637-42034760	K562	blood:	n/a	n/a
7	ATF1	chr19:42032569-42032575	K562	blood:	n/a	n/a
8	ATF1	chr19:42037809-42038256	K562	blood:	n/a	n/a
9	ATF1	chr19:42046751-42046881	K562	blood:	n/a	n/a
10	ATF2	chr19:42041202-42042096	GM12878	blood:	n/a	n/a
11	ATF2	chr19:42037562-42038519	GM12878	blood:	n/a	n/a
12	ATF2	chr19:42041209-42041983	GM12878	blood:	n/a	n/a
13	ATF3	chr19:42007044-42007229	K562	blood:	n/a	n/a
14	BACH1	chr19:41985825-41985834	K562	blood:	n/a	n/a
15	BACH1	chr19:42016903-42017186	K562	blood:	n/a	n/a
16	BACH1	chr19:42048903-42048999	K562	blood:	n/a	n/a
17	BACH1	chr19:42048408-42048594	K562	blood:	n/a	n/a
18	BATF	chr19:42037778-42038228	GM12878	blood:	n/a	n/a
19	BATF	chr19:42027742-42028251	GM12878	blood:	n/a	n/a
20	BATF	chr19:42007315-42007464	GM12878	blood:	n/a	n/a
21	BATF	chr19:42022723-42023153	GM12878	blood:	n/a	n/a
22	BATF	chr19:42027836-42028322	GM12878	blood:	n/a	n/a
23	BATF	chr19:41969389-41969829	GM12878	blood:	n/a	n/a
24	BATF	chr19:42041513-42041943	GM12878	blood:	n/a	n/a
25	BATF	chr19:41969506-41969785	GM12878	blood:	n/a	n/a
26	BCL11A	chr19:42041151-42041932	GM12878	blood:	n/a	n/a
27	BCL11A	chr19:41969464-41969856	GM12878	blood:	n/a	n/a
28	BCL11A	chr19:42041523-42041834	GM12878	blood:	n/a	n/a
29	BCL11A	chr19:41969539-41969773	GM12878	blood:	n/a	n/a
30	BCL11A	chr19:42022922-42023098	GM12878	blood:	n/a	n/a
31	BCL3	chr19:42016218-42016628	GM12878	blood:	n/a	n/a
32	BCL3	chr19:42016667-42016907	GM12878	blood:	n/a	n/a
33	BCL3	chr19:42041346-42042017	GM12878	blood:	n/a	n/a
34	BCL3	chr19:42016314-42016648	GM12878	blood:	n/a	n/a
35	BCLAF1	chr19:42041201-42042022	GM12878	blood:	n/a	n/a
36	BCLAF1	chr19:42037618-42038574	GM12878	blood:	n/a	n/a
37	BCLAF1	chr19:42027598-42028326	GM12878	blood:	n/a	n/a
38	BHLHE40	chr19:41986254-41986585	K562	blood:	n/a	n/a
39	BHLHE40	chr19:41969578-41969860	GM12878	blood:	n/a	n/a
40	BHLHE40	chr19:41985631-41985823	K562	blood:	n/a	n/a
41	BHLHE40	chr19:42041299-42041952	GM12878	blood:	n/a	n/a
42	BHLHE40	chr19:42022983-42023012	GM12878	blood:	n/a	n/a
43	BHLHE40	chr19:42007430-42007554	K562	blood:	n/a	n/a
44	BHLHE40	chr19:42028460-42028816	GM12878	blood:	n/a	chr19:42028587-42028603 chr19:42028585-42028601
45	BHLHE40	chr19:42048495-42048573	GM12878	blood:	n/a	n/a
46	CBX3	chr19:42007176-42007860	HCT-116	colon:	n/a	n/a
47	CBX3	chr19:41968455-41968815	K562	blood:	n/a	n/a
48	CBX3	chr19:41968460-41968804	K562	blood:	n/a	n/a
49	CBX3	chr19:41985547-41986099	K562	blood:	n/a	n/a
50	CEBPB	chr19:41969489-41969670	Hela-S3	cervix:	n/a	chr19:41969517-41969528

(count:305 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:42026012-42026062	Hepatocyte	liver:	n/a
2	chr19:42007378-42007428	HPAEpiC	pulmonary alveolar:	n/a
3	chr19:42007378-42007428	HL-60	blood:	n/a
4	chr19:42007378-42007428	SAEC	small airway:	n/a
5	chr19:42031482-42031532	AoSMC	blood vessel:	n/a
6	chr19:42027798-42027848	K562	blood:	n/a
7	chr19:42026012-42026062	SK-N-SH	brain:	n/a
8	chr19:42027798-42027848	LNCaP	prostate:	n/a
9	chr19:42031482-42031532	SK-N-MC	brain:	n/a
10	chr19:42028551-42028601	NHBE	bronchial:	n/a
11	chr19:42026012-42026062	PFSK-1	brain:	n/a
12	chr19:42027798-42027848	HPAEpiC	pulmonary alveolar:	n/a
13	chr19:42007378-42007428	Hepatocyte	liver:	n/a
14	chr19:42028551-42028601	NH-A	brain:	n/a
15	chr19:42026012-42026062	PrEC	prostate:	n/a
16	chr19:42026012-42026062	SK-N-MC	brain:	n/a
17	chr19:42027798-42027848	AG10803	skin:	n/a
18	chr19:42028551-42028601	HEK293	kidney:	embryo
19	chr19:42026012-42026062	CMK	blood:	n/a
20	chr19:42031482-42031532	SK-N-SH_RA	brain:	n/a
21	chr19:42028551-42028601	HL-60	blood:	n/a
22	chr19:42026012-42026062	HUVEC	blood vessel:	n/a
23	chr19:42031482-42031532	Hela-S3	cervix:	n/a
24	chr19:42026012-42026062	K562	blood:	n/a
25	chr19:42028551-42028601	PANC-1	pancreas:	n/a
26	chr19:42031482-42031532	MCF-7	breast:	n/a
27	chr19:42027798-42027848	HCM	heart:	n/a
28	chr19:42028551-42028601	HRCEpiC	kidney:	n/a
29	chr19:42028551-42028601	IMR90	lung:	fetal
30	chr19:42027798-42027848	Jurkat	blood:	n/a
31	chr19:42027798-42027848	PrEC	prostate:	n/a
32	chr19:42026012-42026062	HCPEpiC	choroid plexus:	n/a
33	chr19:42027798-42027848	NHBE	bronchial:	n/a
34	chr19:42007378-42007428	Hela-S3	cervix:	n/a
35	chr19:42028551-42028601	BE2_C	brain:	n/a
36	chr19:42027798-42027848	IMR90	lung:	fetal
37	chr19:42031482-42031532	GM12892	blood:	n/a
38	chr19:42007378-42007428	GM06990	blood:	n/a
39	chr19:42007378-42007428	HRCEpiC	kidney:	n/a
40	chr19:42007378-42007428	H1-hESC	embryonic stem cell:	embryo
41	chr19:42028551-42028601	GM06990	blood:	n/a
42	chr19:42026012-42026062	SKMC	muscle:	n/a
43	chr19:42027798-42027848	BE2_C	brain:	n/a
44	chr19:42028551-42028601	HIPEpiC	eye:	n/a
45	chr19:42007378-42007428	PANC-1	pancreas:	n/a
46	chr19:42028551-42028601	ECC-1	luminal epithelium:	n/a
47	chr19:42031482-42031532	AG10803	skin:	n/a
48	chr19:42031482-42031532	CMK	blood:	n/a
49	chr19:42031482-42031532	NHBE	bronchial:	n/a
50	chr19:42028551-42028601	GM19239	blood:	n/a

(count:18 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:41955214..41955908-chr19:42043733..42044434,2	MCF-7	breast:
2	chr19:41955365..41955940-chr19:42043884..42044391,2	K562	blood:
3	chr19:41979781..41981328-chr19:41984407..41987088,2	K562	blood:
4	chr19:42044232..42044742-chr19:42076655..42077555,2	MCF-7	breast:
5	chr19:41955066..41955972-chr19:42043125..42044734,10	MCF-7	breast:
6	chr19:42035785..42038762-chr19:42042099..42044984,2	MCF-7	breast:
7	chr19:41945911..41947481-chr19:41988789..41990689,2	K562	blood:
8	chr19:42031680..42033853-chr19:42037171..42039044,2	K562	blood:
9	chr19:42031680..42033653-chr19:42037544..42040304,2	K562	blood:
10	chr19:42048016..42049035-chr19:42076640..42077541,6	MCF-7	breast:
11	chr19:41970790..41973417-chr19:42039173..42040939,2	K562	blood:
12	chr19:42048109..42049006-chr19:42076514..42077838,6	MCF-7	breast:
13	chr19:42048044..42048836-chr19:42069540..42070426,2	K562	blood:
14	chr19:42032930..42034561-chr19:42036519..42039384,2	MCF-7	breast:
15	chr19:41970790..41973417-chr19:42039173..42040939,2	K562	blood:
16	chr19:41944280..41946189-chr19:42004239..42006678,2	K562	blood:
17	chr19:41944061..41946977-chr19:42000429..42002001,2	K562	blood:
18	chr19:41955014..41955888-chr19:42048054..42049030,2	K562	blood:

(count:42 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ATP5SL-1	chr19:42006494-42006559	ENSG00000249527
2	lnc-ATP5SL-1	chr19:41984989-41985192	ENSG00000249527
3	lnc-CEACAM21-3	chr19:42038230-42038534	ENSG00000268355.1
4	lnc-ATP5SL-1	chr19:41985040-41985192	NONHSAT066459
5	lnc-ATP5SL-1	chr19:41984451-41985192	NONHSAT066458
6	lnc-ATP5SL-1	chr19:42001210-42001335	NONHSAT066458
7	lnc-CEACAM21-3	chr19:42037786-42038237	ENSG00000268355.1
8	lnc-ATP5SL-1	chr19:42006494-42006554	ENSG00000267107.2
9	lnc-ATP5SL-1	chr19:42000448-42001335	ENSG00000267107.2
10	lnc-CEACAM21-3	chr19:42037647-42037935	ENSG00000268355.1
11	lnc-ATP5SL-1	chr19:41984989-41985192	ENSG00000267107.2
12	lnc-ATP5SL-1	chr19:42006494-42006554	NONHSAT066453
13	lnc-CEACAM21-2	chr19:42042963-42043266	ENSG00000270164.1
14	lnc-CEACAM21-2	chr19:42042076-42042145	ENSG00000270164.1
15	lnc-ATP5SL-1	chr19:42006494-42006545	NONHSAT066458
16	lnc-CEACAM21-2	chr19:42041860-42041963	ENSG00000270164.1
17	lnc-ATP5SL-1	chr19:41984989-41985051	ENSG00000267107.2
18	lnc-ATP5SL-1	chr19:42006494-42006554	ENSG00000249527
19	lnc-ATP5SL-1	chr19:42001210-42001338	NONHSAT066459
20	lnc-ATP5SL-1	chr19:42000448-42001335	ENSG00000249527
21	lnc-ATP5SL-1	chr19:41962521-41962828	ENSG00000267107.2
22	lnc-ATP5SL-1	chr19:41984989-41985192	ENSG00000249527
23	lnc-CEACAM21-2	chr19:42041545-42043262	ENSG00000270164.1
24	lnc-CEACAM21-2	chr19:42041702-42042145	ENSG00000270164.1
25	lnc-ATP5SL-1	chr19:41984989-41985192	NONHSAT066453
26	lnc-CEACAM21-3	chr19:42037566-42037693	ENSG00000268355.1
27	lnc-ATP5SL-1	chr19:42006494-42006539	ENSG00000267107.2
28	lnc-CEACAM21-2	chr19:42042960-42043266	ENSG00000270164.1
29	lnc-CEACAM21-2	chr19:42042960-42043264	ENSG00000270164.1
30	lnc-ATP5SL-1	chr19:41984989-41985049	ENSG00000267107.2
31	lnc-ATP5SL-1	chr19:41962496-41962828	ENSG00000267107.2
32	lnc-ATP5SL-1	chr19:42006494-42006540	NONHSAT066451
33	lnc-CEACAM21-2	chr19:42042090-42042145	ENSG00000270164.1
34	lnc-ATP5SL-1	chr19:41980371-41980444	ENSG00000267107.2
35	lnc-ATP5SL-1	chr19:41984989-41985192	NONHSAT066451
36	lnc-ATP5SL-1	chr19:42001210-42001335	NONHSAT066451
37	lnc-ATP5SL-1	chr19:42001210-42001335	ENSG00000267107.2
38	lnc-ATP5SL-1	chr19:41984989-41985049	ENSG00000267107.2
39	lnc-ATP5SL-1	chr19:42006494-42006554	ENSG00000249527
40	lnc-ATP5SL-1	chr19:42006494-42006538	NONHSAT066457
41	lnc-ATP5SL-1	chr19:41984451-41985192	NONHSAT066457
42	lnc-CEACAM21-2	chr19:42041929-42041963	ENSG00000270164.1

No data

Variant related genes	Relation type
ENSG00000268355	TF binding region
ENSG00000267107	TF binding region
ENSG00000268034	TF binding region
PLEKHA3P1	TF binding region
ENSG00000270164	TF binding region
ENSG00000268027	TF binding region
ENSG00000268355	CpG island
ENSG00000267107	CpG island
ENSG00000268034	CpG island
PLEKHA3P1	CpG island
ENSG00000270164	CpG island
ENSG00000268027	CpG island
ENSG00000105341	chromatin interactions
ENSG00000268355	chromatin interactions
ENSG00000267107	chromatin interactions
TMED7	miRNA target sites
SPTBN1	miRNA target sites
CHST11	miRNA target sites
PRSS21	miRNA target sites
CNN3	miRNA target sites
EZH2	miRNA target sites

Extended variants
information (count: 2983 )
Associated
traits (count: 69 )

Variant overlapped rSNPs/rCNVs (count:2983 , 50 per page) page: 1 2 3 4 5 6 7 ... 60

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs78273227	chr19:41962522-41962523	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
2	rs187139142	chr19:41962677-41962678	Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
3	rs587728806	chr19:41962678-41962679	Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
4	rs587626320	chr19:41962685-41962686	Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
5	rs115101134	chr19:41962753-41962754	Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
6	rs587770089	chr19:41962828-41962829	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
7	rs587616580	chr19:41962858-41962859	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs113729366	chr19:41962859-41962860	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs587700695	chr19:41962863-41962864	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs375922366	chr19:41962905-41962906	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs142373580	chr19:41962909-41962910	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs146153881	chr19:41962971-41962972	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs587775171	chr19:41963015-41963016	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs60716583	chr19:41963038-41963039	Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs587703533	chr19:41963054-41963055	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs34136957	chr19:41963162-41963163	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs79575907	chr19:41963178-41963179	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs77484903	chr19:41963182-41963183	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs528217494	chr19:41963183-41963184	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs376180352	chr19:41963184-41963185	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs8106702	chr19:41963191-41963192	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs11667701	chr19:41963221-41963222	Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs191999792	chr19:41963337-41963338	Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs587597103	chr19:41963491-41963492	Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs149326612	chr19:41963534-41963535	Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs587728557	chr19:41963563-41963564	Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs10414933	chr19:41963613-41963614	Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs4803471	chr19:41963749-41963750	Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
29	rs369192599	chr19:41963766-41963767	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs587742427	chr19:41963904-41963905	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs182879703	chr19:41963932-41963933	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs587695363	chr19:41963971-41963972	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs376279525	chr19:41963978-41963979	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs587651784	chr19:41963985-41963986	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs386809364	chr19:41963986-41963987	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs7256981	chr19:41963987-41963988	Bivalent Enhancer Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs587645312	chr19:41964042-41964043	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs369033001	chr19:41964043-41964044	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs187166578	chr19:41964059-41964060	Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs191490812	chr19:41964076-41964077	Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs587638259	chr19:41964207-41964208	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs587711807	chr19:41964225-41964226	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs587595365	chr19:41964289-41964290	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs587648736	chr19:41964303-41964304	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs368853002	chr19:41964306-41964307	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs587716265	chr19:41964355-41964356	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs144530019	chr19:41964375-41964376	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs587661533	chr19:41964461-41964462	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs587745674	chr19:41964501-41964502	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs148040227	chr19:41964513-41964514	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:69)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Breast cancer	22522925	CNVD
early-passage human iPS cells	21368824	CNVD
Schizophrenia	18511947	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:918 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41955600-41962600	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
2	chr19:41955800-41963000	Weak transcription	Fetal Intestine Large	intestine
3	chr19:41960400-41962600	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
4	chr19:41961200-41963800	Enhancers	Breast Myoepithelial Primary Cells	Breast
5	chr19:41961400-41962600	Enhancers	GM12878-XiMat	blood
6	chr19:41961400-41962800	Enhancers	Adipose Nuclei	Adipose
7	chr19:41961600-41962800	Bivalent Enhancer	Fetal Muscle Leg	muscle
8	chr19:41961600-41962800	Enhancers	Left Ventricle	heart
9	chr19:41961600-41962800	Enhancers	Spleen	Spleen
10	chr19:41961800-41962600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
11	chr19:41961800-41962800	Enhancers	Fetal Lung	lung
12	chr19:41962000-41962600	Enhancers	Osteobl	bone
13	chr19:41962000-41962800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
14	chr19:41962000-41962800	Enhancers	Ovary	ovary
15	chr19:41962000-41962800	Enhancers	Right Atrium	heart
16	chr19:41962200-41962800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
17	chr19:41962200-41963000	Flanking Active TSS	HUVEC	blood vessel
18	chr19:41962200-41964200	Enhancers	Primary T helper cells fromperipheralblood	blood
19	chr19:41962400-41962800	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
20	chr19:41962400-41963800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
21	chr19:41962400-41964000	Enhancers	Primary T helper cells PMA-I stimulated	--
22	chr19:41962400-41964200	Enhancers	Primary T helper naive cells from peripheral blood	blood
23	chr19:41962400-41964200	Enhancers	Primary T killer memory cells from peripheral blood	blood
24	chr19:41962600-41962800	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
25	chr19:41962600-41962800	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
26	chr19:41962600-41963000	Enhancers	Fetal Thymus	thymus
27	chr19:41962600-41963200	Enhancers	Primary T cells fromperipheralblood	blood
28	chr19:41962600-41963600	Flanking Active TSS	GM12878-XiMat	blood
29	chr19:41962600-41964000	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
30	chr19:41962600-41964000	Enhancers	Primary T regulatory cells fromperipheralblood	blood
31	chr19:41962600-41964200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
32	chr19:41962600-41964400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
33	chr19:41962800-41964200	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
34	chr19:41963000-41963600	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
35	chr19:41963000-41964200	Enhancers	HUVEC	blood vessel
36	chr19:41963200-41964000	Bivalent Enhancer	Primary T cells from cord blood	blood
37	chr19:41963400-41963600	Bivalent Enhancer	A549	lung
38	chr19:41963600-41964200	Enhancers	GM12878-XiMat	blood
39	chr19:41964200-41967400	Weak transcription	HUVEC	blood vessel
40	chr19:41967400-41968400	Enhancers	HUVEC	blood vessel
41	chr19:41968400-41970800	Enhancers	Primary B cells from peripheral blood	blood
42	chr19:41968400-41982200	Weak transcription	HUVEC	blood vessel
43	chr19:41968600-41969200	Enhancers	GM12878-XiMat	blood
44	chr19:41969000-41970600	Enhancers	Primary B cells from cord blood	blood
45	chr19:41969200-41969400	Bivalent Enhancer	Primary hematopoietic stem cells	blood
46	chr19:41969200-41969400	Enhancers	Lung	lung
47	chr19:41969200-41969600	Flanking Active TSS	GM12878-XiMat	blood
48	chr19:41969200-41969600	Enhancers	HepG2	liver
49	chr19:41969200-41969800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
50	chr19:41969200-41970200	Enhancers	Primary monocytes fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links